Escobar, C.; Palacios, B.; Villarreal, M.; Gutiérrez, M.; Capel, M.; Aranda, U.; Hernández, I.; GarcÃa, M.; Lledó, L.; Arenillas, J.F.
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. J. Clin. Med. 2024, 13, 4253.
https://doi.org/10.3390/jcm13144253
AMA Style
Escobar C, Palacios B, Villarreal M, Gutiérrez M, Capel M, Aranda U, Hernández I, GarcÃa M, Lledó L, Arenillas JF.
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. Journal of Clinical Medicine. 2024; 13(14):4253.
https://doi.org/10.3390/jcm13144253
Chicago/Turabian Style
Escobar, Carlos, Beatriz Palacios, Miriam Villarreal, MartÃn Gutiérrez, Margarita Capel, Unai Aranda, Ignacio Hernández, MarÃa GarcÃa, Laura Lledó, and Juan F. Arenillas.
2024. "Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study" Journal of Clinical Medicine 13, no. 14: 4253.
https://doi.org/10.3390/jcm13144253
APA Style
Escobar, C., Palacios, B., Villarreal, M., Gutiérrez, M., Capel, M., Aranda, U., Hernández, I., GarcÃa, M., Lledó, L., & Arenillas, J. F.
(2024). Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. Journal of Clinical Medicine, 13(14), 4253.
https://doi.org/10.3390/jcm13144253
